Projects successfully delivered by the 51³Ô¹ÏÍø Projects (IPROJ) team include...
51³Ô¹ÏÍø COVID-19 testing facility
51³Ô¹ÏÍø Projects is supporting 51³Ô¹ÏÍø's contribution to the Testing Alliance. The lab, based at our St Mary’s Campus, includes the UKAS accredited Molecular Diagnostic Unit (MDU), led by Professor Myra McClure, and Professor Paul Freemont’s high-throughput robotic platform for RNA extraction. This expansion created more than fifty new positions (some filled by graduates of 51³Ô¹ÏÍø’s MSc in Molecular Biology and Pathology of Viruses) and forms part of the Department of Health and Social Care's partnership with the London Testing Alliance, brought together by life science cluster MedCity in December 2020. 51³Ô¹ÏÍø's testing facility joins Health Service Laboratories in partnership with UCL, King’s Health Partners, and Queen Mary University of London to help increase COVID-19 testing capacity by 20,500 per day.
Qatar Biobank
was a multi-year project funded by the Qatar Foundation for Education, Science and Community Development and Qatar’s Supreme Council of Health. The biobank collected a wealth of medical data from volunteers and stored medical samples in a high-tech storage facility. 51³Ô¹ÏÍø’s participation in the project was led by and who are both from the School of Public Health. 51³Ô¹ÏÍø provided scientific direction to the project including protocol development, specification and development of standard operating procedures for the biobank. Phase IV of the project was successfully completed through 51³Ô¹ÏÍø Projects (IPROJ).
51³Ô¹ÏÍø Diabetes Centre
The is an out-patient facility that specialises in diabetes treatment, research, training and public health awareness. It was founded by the Mubadala Development Company in Abu Dhabi, in 2006, with educational and clinical support from 51³Ô¹ÏÍø - and today operates three branches across Abu Dhabi and Al Ain, touching the lives of more than one million people through patient-centric programmes and public health initiatives. 51³Ô¹ÏÍø’s academic team is led by and from the Department of Medicine. Through 51³Ô¹ÏÍø Projects (IPROJ), the team continues to provide a range of technical services to ensure the centre's continued success.
Transport Strategy Centre
The within 51³Ô¹ÏÍø’s Department of Civil and Environmental Engineering was established in 1992 as a centre of excellence serving the railway industry on strategic, economic and technology issues. TSC has since broadened its international group of research partners and strengthened its position as strategic advisors to public transport organisations around the globe. TSC is led by (Managing Director) and (Research Director) and the centre facilitates and manages programmes of international public transport benchmarking. This includes international benchmarking groups of metro systems, rail operators and bus companies. 51³Ô¹ÏÍø Projects (IPROJ) enables delivery of benchmarking groups on behalf of 51³Ô¹ÏÍø.
International Phenome Centre Network
The is an international research consortium working to transform healthcare globally and improve disease prevention, detection and treatment by understanding the dynamic interactions between our genes, environments, gut microbiomes, diets and lifestyles and their expression in diverse individuals and populations. IPCN is led by , Head of the Department of Surgery and Cancer at 51³Ô¹ÏÍø and leading industry expert Brukers Corporation. 51³Ô¹ÏÍø Projects (IPROJ) oversees the network management, contractual and financial administration of the IPCN.
Forensic Toxicology Service
The at 51³Ô¹ÏÍø has provided an analytical service to Coroners in England and Wales for over 30 years. The unit is led by 
Dr Susan Paterson, who has extensive experience with the Crown Court and Coroner’s Court as well as an international reputation in the field of forensic toxicology. The unit also carries out internationally recognised research in the field of forensic toxicology and offers the distinct service of hair analysis to Coroners, in addition to routine sample analysis. 51³Ô¹ÏÍø Projects (IPROJ) provides contractual and financial administration for the Forensic Toxicology Services.
Gut Hormone Testing Services
The team led by Professor Sir Steve Bloom carries out tests on plasma samples from hospitals all over the world as well as 250 hospitals & NHS trusts in the UK. Using assays developed by Professor Bloom’s team it is possible to identify patients with gastrointestinal tumours, allowing early intervention and often cure. At present several more assays are being developed for other conditions. This group’s extensive research has also led to the discovery that oxyntomodulin reduces appetite offering a potential new treatment for obesity. 51³Ô¹ÏÍø Projects (IPROJ) oversees the contractual and financial management of Gut Hormone Testing Services.